Appetite Control: Reduced hunger and cravings supported sustainable calorie reduction and long-term weight management
Respuesta en diabetes tipo 2 : En personas con diabetes tipo 2, la respuesta a GLP-1 est relativamente preservada aunque atenuada, mientras que la respuesta a GIP est frecuentemente disminuida, lo que inicialmente llev a los investigadores a enfocarse en agonistas de GLP-1
SURMOUNT-1 (N=2,539) showed tirzepatide 15 mg produced 20.9% mean weight loss at 72 weeks, compared to 3.1% for placebo [2]
"Structure-function of the glucagon receptor family of G protein-coupled receptors, coupled to: the glucagon, GIP, GLP-1, and GLP-2 receptors"
Its important to understand both the bright side and the risks of this therapy to set realistic expectations
To Learn More About FMU go to: We Accept 150 New Students Every 90 Days